Datar Cancer Genetics (India)

Datar Cancer Genetics is a molecular oncology company founded in India with a global presence across more than 50 countries. It provides precision cancer testing personalized to cancer biology and the treatment journey, using comprehensive tissue profiling and advanced liquid biopsies to analyze molecular biomarkers across the continuum of care, from early detection and initial diagnosis to treatment selection, recurrence monitoring, and late-stage disease management. Its commitment to global quality is anchored by CellDx-Tissue, described as India's first and only US FDA-cleared comprehensive genomic profiling (CGP) assay. The company operates an FDA Registered Facility and is CAP-Accredited and CLIA Certified, and states it is trusted by oncologists across 50+ countries.

Datar Cancer Genetics is a molecular oncology company founded in India with a global presence across more than 50 countries. It was established to address the belief that cancer treatment had for too long been guided by population averages, and it built a better way through advanced liquid biopsy, comprehensive tissue profiling, and functional testing on live tumor cells. The company provides oncologists with molecular clarity to make decisions that are precise, personalized, and evidence-backed at every stage of the cancer journey. Its commitment to global quality is anchored by CellDx-Tissue, described as India's first and only US FDA-cleared comprehensive genomic profiling (CGP) assay.

Precision cancer testing personalized to cancer biology and the treatment journey; evidence over assumptions, data over averages.

• CellDx-Tissue

  Described as India's first and only US FDA-cleared comprehensive genomic profiling (CGP) assay.

1. 1Precision Oncology & Non-Invasive Cancer Tests | Datar Cancer Geneticsdatarpgx.com
2. 2Datar Cancer Geneticsdatarpgx.com